168 related articles for article (PubMed ID: 20570056)
41. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant.
Sureau C; Salisse J
Hepatology; 2013 Mar; 57(3):985-94. PubMed ID: 23161433
[TBL] [Abstract][Full Text] [Related]
42. A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins.
Tsukuda S; Watashi K; Hojima T; Isogawa M; Iwamoto M; Omagari K; Suzuki R; Aizaki H; Kojima S; Sugiyama M; Saito A; Tanaka Y; Mizokami M; Sureau C; Wakita T
Hepatology; 2017 Apr; 65(4):1104-1116. PubMed ID: 27863453
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation and clinical significance of HBV large protein (LHBs) in diagnosis of hepatitis B].
Chen YJ; Zhou YL; Xia J; Xia WW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):241-3. PubMed ID: 17971933
[TBL] [Abstract][Full Text] [Related]
44. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.
Yan H; Li W
Dig Dis; 2015; 33(3):388-96. PubMed ID: 26045274
[TBL] [Abstract][Full Text] [Related]
45. Latent hepatitis B virus (HBV) infection and HBV DNA integration is associated with further transformation of hepatoma cells in vitro.
Favre D; Petit MA; Trépo C
ALTEX; 2003; 20(3):131-42. PubMed ID: 12947486
[TBL] [Abstract][Full Text] [Related]
46. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection.
Sengupta S; Rehman S; Durgapal H; Acharya SK; Panda SK
J Med Virol; 2007 Mar; 79(3):220-8. PubMed ID: 17245717
[TBL] [Abstract][Full Text] [Related]
47. The tupaia model for the study of hepatitis B virus: direct infection and HBV genome transduction of primary tupaia hepatocytes.
von Weizsäcker F; Köck J; MacNelly S; Ren S; Blum HE; Nassal M
Methods Mol Med; 2004; 96():153-61. PubMed ID: 14762267
[No Abstract] [Full Text] [Related]
48. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.
Tsuge M; Hiraga N; Akiyama R; Tanaka S; Matsushita M; Mitsui F; Abe H; Kitamura S; Hatakeyama T; Kimura T; Miki D; Mori N; Imamura M; Takahashi S; Hayes CN; Chayama K
J Gen Virol; 2010 Jul; 91(Pt 7):1854-64. PubMed ID: 20219897
[TBL] [Abstract][Full Text] [Related]
49. Fibronectin is essential for hepatitis B virus propagation in vitro: may be a potential cellular target?
Yang J; Ding X; Zhang Y; Bo X; Zhang M; Wang S
Biochem Biophys Res Commun; 2006 Jun; 344(3):757-64. PubMed ID: 16631116
[TBL] [Abstract][Full Text] [Related]
50. Microfluidic platform for hepatitis B viral replication study.
Sodunke TR; Bouchard MJ; Noh HM
Biomed Microdevices; 2008 Jun; 10(3):393-402. PubMed ID: 18165913
[TBL] [Abstract][Full Text] [Related]
51. Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications.
Li W; Urban S
J Hepatol; 2016 Apr; 64(1 Suppl):S32-S40. PubMed ID: 27084034
[TBL] [Abstract][Full Text] [Related]
52. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
Shim JK; Lee YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
[TBL] [Abstract][Full Text] [Related]
53. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration.
Gripon P; Diot C; Guguen-Guillouzo C
Virology; 1993 Feb; 192(2):534-40. PubMed ID: 8421898
[TBL] [Abstract][Full Text] [Related]
54. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.
Gripon P; Le Seyec J; Rumin S; Guguen-Guillouzo C
Virology; 1995 Nov; 213(2):292-9. PubMed ID: 7491754
[TBL] [Abstract][Full Text] [Related]
55. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice.
Brown JJ; Parashar B; Moshage H; Tanaka KE; Engelhardt D; Rabbani E; Roy-Chowdhury N; Roy-Chowdhury J
Hepatology; 2000 Jan; 31(1):173-81. PubMed ID: 10613743
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts.
Schieck A; Schulze A; Gähler C; Müller T; Haberkorn U; Alexandrov A; Urban S; Mier W
Hepatology; 2013 Jul; 58(1):43-53. PubMed ID: 23292963
[TBL] [Abstract][Full Text] [Related]
57. Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus.
Gudima S; Meier A; Dunbrack R; Taylor J; Bruss V
J Virol; 2007 Apr; 81(8):4343-7. PubMed ID: 17251287
[TBL] [Abstract][Full Text] [Related]
58. A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.
Saso W; Tsukuda S; Ohashi H; Fukano K; Morishita R; Matsunaga S; Ohki M; Ryo A; Park SY; Suzuki R; Aizaki H; Muramatsu M; Sureau C; Wakita T; Matano T; Watashi K
Biochem Biophys Res Commun; 2018 Jun; 501(2):374-379. PubMed ID: 29730285
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the anti-HBV activity of HLP1-23, a human lactoferrin-derived peptide.
Florian PE; Macovei A; Lazar C; Milac AL; Sokolowska I; Darie CC; Evans RW; Roseanu A; Branza-Nichita N
J Med Virol; 2013 May; 85(5):780-8. PubMed ID: 23508903
[TBL] [Abstract][Full Text] [Related]
60. Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells.
Yamada M; Oeda A; Jung J; Iijima M; Yoshimoto N; Niimi T; Jeong SY; Choi EK; Tanizawa K; Kuroda S
J Control Release; 2012 Jun; 160(2):322-9. PubMed ID: 22100387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
